1100 13th Street, NW, Suite 750Washington, DC 20005202.887.6400Customer Service: 800.544.0155
All Contents © 2019The Kiplinger Washington Editors
When investors think of biotech stocks, visions of Amgen (AMGN) and Gilead (
Our picks should deliver solid long-term gains with less drama than the racy tech and biotech stocks strutting in the limelight.
Investors should be ready for a bumpy ride. One step concerned investors can take to ramp down risk could be to buy into a stock market index that offers more stability than the S&P 500: the S&P 500 Low...
More Investing News »